simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;5^{th}-Individual ID 66;;;95^{th}-Individual ID 69;95^{th}-Individual ID 69;95^{th}-Individual ID 69;95^{th}-Individual ID 69;95^{th}-Individual ID 69
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.427557127230158;0.145695148658126;-0.246898289929409;-0.447621691960507;0.893984486815901;;;-0.33204081363278;0.0636661072865741;-0.238961805186102;-0.448200759884798;0.837365030050208
;-0.444131842249037;0.132354865122291;-0.255497397639616;-0.474500299513994;0.868501262441745;;;-0.345644964496878;0.057481206900129;-0.246307787992104;-0.476889731190748;0.819274407323006
;-0.410982412211279;0.159035432193962;-0.238299182219202;-0.420743084407019;0.919467711190057;;;-0.318436662768682;0.0698510076730192;-0.231615822380099;-0.419511788578848;0.85545565277741
;0.999555051607054;0.997522795543986;0.999640818731176;0.998933092497214;0.999759373551828;;;0.999503015168782;0.997212367200161;0.999720153186468;0.9987878479233;0.999861765502006
;3.98392642468256e-06;5.23666391871293e-05;2.88939015013858e-06;1.47951059852301e-05;1.58429210697123e-06;;;4.70292797933085e-06;6.25181041889945e-05;1.98703665165206e-06;1.79177111834884e-05;6.89813254271113e-07
